Stock Events

Stock Events

Marker Therapeutics (MRKR) Q2 2026 Earnings

15MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.53

-0.39

-0.26

-0.12

Details

Expected EPS

-0.16

Actual EPS

-0.16

Surprise EPS

0

Surprise Percent

+0%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.16 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.